[1]梁咏欣 卢蔚起 赵先明.基于网络药理学探讨海藻治疗甲状腺结节作用机制[J].国际中医中药杂志,2021,43(10):1018-1022.[doi:10.3760/cma.j.cn115398-20200702-00037]
 Liang Yongxin,Lu Weiqi,Zhao Xianming.Mechanism study of Sargassum in the treatment of thyroid nodule based on network pharmacology[J].,2021,43(10):1018-1022.[doi:10.3760/cma.j.cn115398-20200702-00037]
点击复制

基于网络药理学探讨海藻治疗甲状腺结节作用机制

参考文献/References:

[1] 于钏钏,王强. 2008—2014年我国健康成人甲状腺结节流行特征及影响因素初步分析[J]. 环境与健康杂志,2016,33(5): 440-443. DOI:10.16241/j.cnki.1001-5914.2016.05.016.

[2] 李家腾,段洁,张莎莎,等. 青岛近海五种海藻营养成分分析[J]. 营养学报,2018,40(1):101-103. DOI:10.13325/j.cnki. acta.nutr.sin.2018.01.028.

[3] 熊佳. 海藻治疗甲状腺疾病研究进展[J]. 实用中医药杂志, 2019,35(7):902-903.

[4] 刘坤,吴心力,王英丽. 海藻玉壶汤联合左旋甲状腺素钠片治疗甲状腺腺瘤临床观察[J]. 世界最新医学信息文摘,2019, 19(78):177-178. DOI:10.19613/j.cnki.1671-3141.2019.78.111.

[5] 白龙,王歌,杨宇峰. 逍遥散合海藻玉壶汤加减治疗甲状腺肿瘤术后的临床研究[J]. 中医药导报,2019,25(22):66-69. DOI:10.13862/j.cnki.cn43-1446/r.2019.22.020.

[6] 陈玲,郭盼盼,万会娜,等. 中医药治疗甲状腺结节的研究进展[J]. 河北中医,2019,41(12):1914-1920. DOI:10.3969/j. issn.1002-2619.2019.12.034.

[7] 孙阳,车艳新,吴勃岩. 槲皮素抗肿瘤药理作用及剂型研究进展[J]. 现代医药卫生,2016,32(20):3142-3144.

[8] Zheng SY,Li Y,Jiang D,et al. Anticancer effect and apoptosis induction by quercetin in the human lung cancer cell line A-549[J]. Mol Med Rep,2012,5(3):822-826. DOI:10.3892/ mmr.2011.726.

[9] Sharma A,Kashyap D,Sak K,et al. Therapeutic charm of quercetin and its derivatives:a review of research and patents[J]. Pharm Pat Anal,2018,7(1):15-32. DOI:10.4155/ ppa-2017-0030.

[10] Ackland ML,van de Waarsenburg S,Jones R. Synergistic antiproliferative action of the flavonols quercetin and kaempferol in cultured human cancer cell lines[J]. In Vivo,2005,19(1):69-76.

[11] Lee YS,Shin KH,Kim BK,et al. Anti-diabetic activities of fucosterol from Pelvetia siliquosa[J]. Arch Pharm Res,2004, 27(11):1120-1122. DOI:10.1007/BF02975115.

[12] 谷寅. 甲状腺乳头状癌合并桥本甲状腺炎免疫微环境分析[D]. 天津:天津医科大学,2015.

[13] 余元勋. 中国分子肝癌学[M]. 合肥:安徽科学技术出版社, 2016:162-166.

[14] Bendardaf R,Sharif-Askari FS,Sharif-Askari NS,et al. Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA,Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer[J]. Anticancer Res,2019, 39(4):1953-1957. DOI:10.21873/anticanres.13305.

相似文献/References:

[1]杨小玲 谢军芳.扶正疏肝方联合左旋甲状腺素对甲状腺结节的干预作用[J].国际中医中药杂志,2016,38(09):800.[doi:10.3760/cma.j.issn.1673-4246.2016.09.010]
 Yang Xiaoling,Xie Junfang..Clinical observation of Fuzheng-Shugan decoction on treating thyroid nodule [J].,2016,38(10):800.[doi:10.3760/cma.j.issn.1673-4246.2016.09.010]
[2]何欢 彭艳文 刘颖 薛婧 赵锡艳 徐心瑶 李鸣镝.糖尿病患者发生甲状腺结节的危险因素及与中医体质的相关性分析[J].国际中医中药杂志,2021,43(04):329.[doi:10.3760/cma.j.cn115398-20201026-00155]
 He Huan,Peng Yanwen,Liu Ying,et al.Risk factors of thyroid nodule in diabetic patients and the correlation with Traditional Chinese Medicine constitution[J].,2021,43(10):329.[doi:10.3760/cma.j.cn115398-20201026-00155]

备注/Memo

通信作者:赵先明,Email: 13682229138@163.com

基金项目:广东省医学科学技术研究基金(B2018174)

更新日期/Last Update:

2021-10-14